
Geno10X Biosciences Ltd is a Canadian AI-enabled medical device startup focused on revolutionizing disease risk prediction through a rapid disease detection platform. Their mission is to provide an intelligent, non-invasive, rapid, and accurate testing solution that is accessible to everyone. The company utilizes proprietary dyes, quantum dots, and next-generation imaging sensors to achieve high sensitivity and specificity in detecting molecular biomarkers in urine samples. Their decentralized Point of Care Testing (POCT) stations streamline sample processing and interpretation, significantly reducing the burden on healthcare systems. By collaborating with local governments, healthcare clinics, and top Canadian research labs, Geno10X aims to enhance disease detection and enable timely interventions by physicians, all while maintaining cost-effectiveness compared to traditional testing methods.

Geno10X Biosciences Ltd is a Canadian AI-enabled medical device startup focused on revolutionizing disease risk prediction through a rapid disease detection platform. Their mission is to provide an intelligent, non-invasive, rapid, and accurate testing solution that is accessible to everyone. The company utilizes proprietary dyes, quantum dots, and next-generation imaging sensors to achieve high sensitivity and specificity in detecting molecular biomarkers in urine samples. Their decentralized Point of Care Testing (POCT) stations streamline sample processing and interpretation, significantly reducing the burden on healthcare systems. By collaborating with local governments, healthcare clinics, and top Canadian research labs, Geno10X aims to enhance disease detection and enable timely interventions by physicians, all while maintaining cost-effectiveness compared to traditional testing methods.